Healthc’Air: A new era in pharmaceutical logistical services
The logistics sector enters the pharmaceutical air in a new stage with the official launch of the Healthc’Air, a pioneering entity that has been appointed to revolutionize the management of high temperature drug shipments around the world. Under the leadership of Yulia Celitaria, global director Parma and a recognized expert in this field, he creates a healthc’air immediately the same as a basic partner for airlines and GSAs with the aim of reaching new excellence standards.
Unique experience
At launch, Healthc’Air proudly declares two main agents: ECS GROUP and Global GSA, both of whom are respected leaders in this industry. This early market confidence confirms the importance of the unique supply designed to provide the actors in the sector with the expertise and added value that is unparalleled by any other GSA today. Healthc’Air has already attracted the attention of more than ten airlines in different stages of developing their drug products.
Units, developmental and sustainable
Healthc’Air offers a multi -level approach (launch, advanced, confidence) allows every airline to choose the scope of services according to its needs: consultations, audit, full shipping management, training, operation, certification support, digital tools, among other things. Several service models will be tried during the year 2025 to design the offer for actual demand in the market. Sustainability is essential for the Healthc’Air task, with “green logistical” solutions designed to support the environmental transition to the pharmaceutical supply chain.
Treating emerging challenges
Healthc’Air has been created to address critical challenges: lack of specialized experience, organizational complexity, improvement of the process, risk management, digital transformation, and compliance with environmental standards. This entity provides concrete solutions through an international team of pharmaceutical ambassadors, operational excellence experts, and a network of strategic partners.
“Our ambition in Healthc’Air is to overcome the current industry standards. We aim to build, along with our customers, and solutions that combine operational excellence, digital innovation and sustainable commitment. By listening closely to the real market needs and gathering senior experts, we will convert the drugs to the air drugs in a sustainable way.” Yulia Celitaria, World Manager Pharma, Healthc’Air
